The role of the oncofetal H19 lncRNA in tumor metastasis: orchestrating the EMT-MET decision

Imad J. Matouk; David Halle; Eli Raveh; Michal Gilon; Vladimir Sorin; Avraham Hochberg

doi:10.18632/oncotarget.6387

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

The role of the oncofetal H19 lncRNA in tumor metastasis: orchestrating the EMT-MET decision

Imad J. Matouk _, David Halle, Eli Raveh, Michal Gilon, Vladimir Sorin and Avraham Hochberg

PDF | HTML | How to cite

Oncotarget. 2016; 7:3748-3765. https://doi.org/10.18632/oncotarget.6387

Metrics: PDF 3640 views | HTML 3844 views | ?

Abstract

Imad J. Matouk1,2,*, David Halle1, Eli Raveh1, Michal Gilon1, Vladimir Sorin1 and Avraham Hochberg1

1 Department of Biological Chemistry, Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel

2 Department of Biological Sciences, Faculty of Science and Technology, Al-Quds University, Jerusalem, West Bank

Correspondence to:

Imad J. Matouk, email:

Keywords: H19, miR-675, metastasis, lncRNA, EMT, MET

Received: June 16, 2015 Accepted: November 15, 2015 Published: November 25, 2015

Abstract

Long non-coding RNA (lncRNA) genes are emerging as key players in the metastatic cascade. Current evidence indicate that H19 lncRNA and the microRNA(miRNA) miR-675, which is processed from it, play crucial roles in metastasis, through the regulation of critical events specifically the epithelial to mesenchymal (EMT) and the mesenchymal to epithelial transitions (MET). This review summarizes recent mechanistic pathways and tries to put together seemingly conflicting data from different reports under one proposed general scheme underlying the various roles of H19/miR-675 in the metastatic cascade. We propose several approaches to harnessing this knowledge for translational medicine.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 6387

Publication Alerts

Reviews:

The role of the oncofetal H19 lncRNA in tumor metastasis: orchestrating the EMT-MET decision

Abstract